Buscar resultados de ensayos clínicos
Burkitt Lymphoma - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma Condición:
Fecha: 2011-02-02 Intervenciones: Drug: Chemotherapy-Rituximab combination Short cycles of high-dose and conventional chemotherapy in comb |
Terminated |
Nombre del estudio: Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma Condición:
|
Completed |
Nombre del estudio: Rituximab Combined With Chemotherapy in Burkitt`s Lymphoma Condición:
Fecha: 2006-10-13 Intervenciones: Drug: RITUXIMAB 375 mg/m2/d day 1 |
Completed |
Nombre del estudio: Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma Condición:
Fecha: 2012-01-06 Intervenciones:
|
Completed |
Nombre del estudio: LMBA02 Protocol for Patients With a Burkitt Lymphoma Condición: Burkitt Lymphoma Fecha: 2005-09-12 Intervenciones: Drug: rituximab |
Terminated |
Nombre del estudio: Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL Condición: Burkitt Lymphoma Fecha: 2005-09-12 Intervenciones: Drug: Rituximab |
Active, not recruiting |
Nombre del estudio: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Condición:
|
Completed |
Nombre del estudio: Forodesine Hydrochloride (BCX-1777) for B-Cell Acute Lymphoblastic Leukemia Condición: B-cell Acute Lymphoblastic Leukemia Fecha: 2006-02-08 Intervenciones: Drug: forodesine hydrochloride (BCX-1777) |
Recruiting |
Nombre del estudio: The Safety and Efficacy of CART-19 Cells in B-cell Acute Lymphoblastic Leukemia (B-ALL). Condición: B-cell Acute Lymphoblastic Leukemia Fecha: 2016-09-29 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Condición: Relapsed B-Cell Acute Lymphoblastic Leukemia Fecha: 2013-05-21 Intervenciones:
|